Campath: from innovation to impact 01 August 2009 The path from innovation to impact can be long and complex. Here we describe the 30-year journey behind the development of a drug now being used to treat multiple sclerosis. Read More
New hopes for the nervous system: multiple sclerosis 01 January 2009 Cambridge neurologists have shown that an antibody used to treat leukaemia also limits and repairs the damage in multiple sclerosis. Read More